Additionally, given ATM’s critical role in maintaining genomic stability across various tissues, the long-term inhibition of ATM by AZD1390 could potentially disrupt immune function or impair tumor suppression, thereby increasing cancer risk. This evidence concerns the gene ATM and neoplasm.